Vitner Einat B, Futerman Anthony H
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Handb Exp Pharmacol. 2013(216):405-19. doi: 10.1007/978-3-7091-1511-4_20.
Gaucher disease is an inherited metabolic disease caused by the defective activity of the lysosomal enzyme, glucosylceramidase (GlcCerase), which is responsible for the last step in the degradation of complex glycosphingolipids. As a result, glucosylceramide (GlcCer) accumulates intracellularly. Little is known about the mechanisms by which GlcCer accumulation leads to Gaucher disease, particularly for the types of the disease in which severe neuropathology occurs. We now summarize recent advances in this area and in particular focus in the biochemical and cellular pathways that may cause neuronal defects. Most recent work has taken advantage of newly available mouse models, which mimic to a large extent human disease progression. Finally, we discuss observations of a genetic link between Gaucher disease and Parkinson's disease and discuss how this link has stimulated research into the basic biology of the previously underappreciated glycosphingolipid, GlcCer.
戈谢病是一种遗传性代谢疾病,由溶酶体酶葡萄糖脑苷脂酶(GlcCerase)活性缺陷引起,该酶负责复合糖鞘脂降解的最后一步。结果,葡萄糖脑苷脂(GlcCer)在细胞内蓄积。对于GlcCer蓄积导致戈谢病的机制知之甚少,尤其是对于发生严重神经病理学改变的疾病类型。我们现在总结该领域的最新进展,特别关注可能导致神经元缺陷的生化和细胞途径。最近的研究利用了新出现的小鼠模型,这些模型在很大程度上模拟了人类疾病的进展。最后,我们讨论戈谢病与帕金森病之间遗传联系的观察结果,并讨论这种联系如何激发了对之前未得到充分重视的糖鞘脂GlcCer基础生物学的研究。